http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104146966-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate | 2013-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104146966-B |
| titleOfInvention | Dutasteride self-microemulsion freeze-dried composition and preparation method thereof |
| abstract | The invention discloses a dutasteride self-microemulsion freeze-drying composition and a preparation method thereof, wherein the dutasteride self-microemulsion freeze-drying composition comprises a dutasteride self-microemulsion and a freeze-drying excipient in a weight ratio of 0.5-2: 1, wherein the dutasteride self-microemulsion mainly comprises the following components in percentage by weight: 0.05-0.3% of dutasteride, 5-75% of oil phase, 20-60% of emulsifier and 4-50% of co-emulsifier. The freeze-dried composition is more suitable for manufacturing a dutasteride solid preparation, and can improve the bioavailability of dutasteride. |
| priorityDate | 2013-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.